Recent research found a correlation between the upfront time to build and release a clinical database and its impact on downstream data management processes in conducting and completing trials.

Clinical trials are constantly pushing the boundaries of innovation. Over the past few years, there’s been an explosion of advancements, such as the widespread use of biomarkers in precision medicine, ...

The commercial success of existing lipid-lowering medications highlights the enormous market potential for effective ...

Schools throughout Utah are grappling with how to properly use or restrict the use of artificial intelligence. Although ...

First, my colleague, Frances Stead Sellers will talk to Amir Dan Rubin, founder and CEO of the VC firm Healthier Capital. He was previously the CEO of One Medical and Stanford Healthcare. We're ...